Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ARMK Stock Summary
In the News

Aramark (ARMK) Q4 2023 Earnings Call Transcript
Aramark (NYSE:ARMK ) Q4 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Felise Kissell - Senior Vice President, Investor Relations & Corporate Development John Zillmer - CEO Tom Ondrof - CFO Conference Call Participants Harry Martin - Bernstein Neil Tyler - Redburn Atlantic Ian Zaffino - Oppenheimer Andrew Steinerman - JPMorgan Heather Balsky - BOA Andrew Wittmann - Baird Toni Kaplan - Morgan Stanley Shlomo Rosenbaum - Stifel Josh Chan - UBS Stephanie Moore - Jefferies Operator Good morning, and welcome to Aramark's Fourth Quarter and Full Year Fiscal 2023 Earnings Results Conference Call. My name is Kevin, and I'll be your operator for today's call.

Aramark tops revenue expectations as profit matches, and stock slips
Shares of Aramark ARMK, slipped 0.1% in premarket trading Tuesday, after the food and facilities company matched fiscal fourth-quarter profit expectations but beat revenue forecasts. Net income for the quarter to Sept.

Unlocking Q4 Potential of Aramark (ARMK): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Aramark (ARMK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2023.

IPOs are out of fashion. Here's what companies are doing instead.
While the current deal landscape on Wall Street remains low on M&A, initial public offerings (IPOs), and other transactions, corporate spinoffs are chugging along.

Vestis: A Look At The Aramark Spinoff
Aramark has completed the spinoff of its uniform and workplace business supplies segment now called Vestis. Vestis is a $2.7 billion business with a focus on uniforms and workwear, aiming for 5-7% growth in the next five years. The market response to the spinoff has been mixed, although shares of Vestis could see upside if margin achievements will be delivered upon.

Aramark investors should root for an Astros-Phillies World Series rematch, or a Blue Jays surprise, analyst says
If you're an investor in the shares of Aramark, which provides food and hospitality services for many professional sports teams, then you should be rooting for the Houston Astros and the Philadelphia Phillies to return to the World Series.

Aramark Stock Appears to Be Down Big Today: Here's What's Really Going On
Aramark has completed the spinoff of its uniform business. Shareholders now own one share of Vestis, the new company, for every two shares of Aramark they owned on Friday.

The 7 Most Undervalued Mid-Cap Stocks to Buy in September 2023
Now looks like a good time to consider undervalued mid-cap stocks. According to Franklin Templeton, the grouping of companies with market capitalizations between $2 billion to $10 billion is due for further improvement.

Aramark to Participate in Upcoming Citi Investor Conference
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE:ARMK), a global leader in food, facilities management and uniforms, announced that the Company's Chief Financial Officer, Tom Ondrof, and Chief Operating Officer, International, Carl Mittleman, will participate in Citi's 2023 Growth Conference in London on September 15, 2023, with a featured Fireside Chat session beginning at 11:20 a.m. BST / 6:20 a.m. EDT. A live webcast and replay of the fireside chat sessions will be available through the Investor.

Aramark spinoff Vestis' stock to begin trading on the NYSE in October
Aramark ARMK said Wednesday that the spinoff of its uniforms and workplace supplies business, which will be named Vestis, has been approved and is expected to be completed on Sept. 30. the food, facilities management and uniforms company said holders of Aramark shares will receive on Vestis common stock for every two Aramark shares they own as of Sept.
ARMK Financial details
ARMK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-29
Metric | History | 2019-09-27 | 2020-10-02 | 2021-10-01 | 2022-09-30 | 2023-09-29 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 65.74 | 50.95 | 47.48 | 63.45 | 72.35 | |
Net income per share | 1.82 | -1.83 | -0.36 | 0.76 | 2.59 | |
Operating cash flow per share | 3.99 | 0.7 | 2.58 | 2.7 | 2.94 | |
Free cash flow per share | 2.02 | -0.75 | 1.11 | 1.28 | 1.28 | |
Cash per share | 1 | 9.96 | 2.09 | 1.28 | 7.53 | |
Book value per share | 13.45 | 10.86 | 10.69 | 11.77 | 14.25 | |
Tangible book value per share | -17.1 | -17.99 | -18.78 | -17.84 | -14.97 | |
Share holders equity per share | 13.45 | 10.86 | 10.69 | 11.77 | 14.25 | |
Interest debt per share | 28.43 | 40.01 | 32.33 | 31.74 | 34.79 | |
Market cap | 7.67B | 5.01B | 6.58B | 5.8B | 6.53B | |
Enterprise value | 14.1B | 12.19B | 13.88B | 13.25B | 13.19B | |
P/E ratio | 17.09 | -10.85 | -71.35 | 29.81 | 9.68 | |
Price to sales ratio | 0.47 | 0.39 | 0.54 | 0.36 | 0.35 | |
POCF ratio | 7.79 | 28.35 | 10.01 | 8.35 | 8.52 | |
PFCF ratio | 15.37 | -26.68 | 23.36 | 17.58 | 19.53 | |
P/B Ratio | 2.31 | 1.83 | 2.42 | 1.91 | 1.76 | |
PTB ratio | 2.31 | 1.83 | 2.42 | 1.91 | 1.76 | |
EV to sales | 0.87 | 0.95 | 1.15 | 0.81 | 0.7 | |
Enterprise value over EBITDA | 10.62 | 23.05 | 18.7 | 11.42 | 9.36 | |
EV to operating cash flow | 14.33 | 69 | 21.13 | 19.08 | 17.21 | |
EV to free cash flow | 28.26 | -64.93 | 49.27 | 40.19 | 39.46 | |
Earnings yield | 0.06 | -0.09 | -0.01 | 0.03 | 0.1 | |
Free cash flow yield | 0.07 | -0.04 | 0.04 | 0.06 | 0.05 | |
Debt to equity | 2.01 | 3.54 | 2.88 | 2.57 | 2.32 | |
Debt to assets | 0.49 | 0.62 | 0.54 | 0.52 | 0.51 | |
Net debt to EBITDA | 4.85 | 13.58 | 9.84 | 6.42 | 4.73 | |
Current ratio | 0.98 | 1.99 | 1.01 | 1 | 1.04 | |
Interest coverage | 2.66 | -0.17 | 0.48 | 1.65 | 1.96 | |
Income quality | 2.19 | -0.38 | -7.13 | 3.58 | 1.14 | |
Dividend Yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Payout ratio | 0.24 | -0.24 | -1.21 | 0.58 | 0.17 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.55 | 0.46 | 0.52 | 0.51 | 0.45 | |
Capex to operating cash flow | -0.49 | -2.06 | -0.57 | -0.53 | -0.56 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | |
Capex to depreciation | -0.82 | -0.61 | -0.68 | -0.69 | -0.79 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.01 | 0 | |
Graham number | 23.45 | 21.16 | 9.33 | 14.15 | 28.8 | |
ROIC | 0.07 | 0 | 0.01 | 0.04 | 0.05 | |
Return on tangible assets | 0.07 | -0.05 | -0.01 | 0.03 | 0.07 | |
Graham Net | -34.83 | -36.4 | -37.66 | -38.19 | -35.02 | |
Working capital | -46.91M | 2.33B | 41.42M | 6.1M | 190.06M | |
Tangible asset value | -4.22B | -4.53B | -4.78B | -4.59B | -3.9B | |
Net current asset value | -7.75B | -8.29B | -8.75B | -8.75B | -7.93B | |
Invested capital | 2.01 | 3.54 | 2.88 | 2.57 | 2.32 | |
Average receivables | 1.8B | 1.62B | 1.59B | 1.95B | 2.26B | |
Average payables | 1.01B | 831.49M | 791.27M | 1.12B | 1.36B | |
Average inventory | 568.06M | 423.9M | 424.57M | 482.53M | 565.41M | |
Days sales outstanding | 40.64 | 40.72 | 52.76 | 48.02 | 45.76 | |
Days payables outstanding | 25.1 | 20.19 | 30.48 | 32.7 | 30.13 | |
Days of inventory on hand | 10.33 | 13.28 | 13.68 | 13.65 | 12.39 | |
Receivables turnover | 8.98 | 8.96 | 6.92 | 7.6 | 7.98 | |
Payables turnover | 14.54 | 18.08 | 11.98 | 11.16 | 12.11 | |
Inventory turnover | 35.33 | 27.48 | 26.67 | 26.73 | 29.46 | |
ROE | 0.14 | -0.17 | -0.03 | 0.06 | 0.18 | |
Capex per share | -1.97 | -1.45 | -1.47 | -1.42 | -1.66 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-29 for Q4
Metric | History | 2022-09-30 | 2022-12-30 | 2023-03-31 | 2023-06-30 | 2023-09-29 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17.01 | 17.73 | 17.65 | 18.2 | 18.76 | |
Net income per share | 0.29 | 0.29 | 0.21 | 1.3 | 0.79 | |
Operating cash flow per share | 3.24 | -2.34 | 1.21 | 0.09 | 3.97 | |
Free cash flow per share | 2.84 | -2.72 | 0.88 | -0.31 | 3.5 | |
Cash per share | 1.28 | 1.18 | 1.16 | 1.54 | 7.51 | |
Book value per share | 11.74 | 12.11 | 12.21 | 13.61 | 14.21 | |
Tangible book value per share | -17.78 | -17.32 | -17.2 | -15.78 | -14.93 | |
Share holders equity per share | 11.74 | 12.11 | 12.21 | 13.61 | 14.21 | |
Interest debt per share | 30.58 | 33.27 | 32.65 | 31.17 | 33.44 | |
Market cap | 5.82B | 7.74B | 6.74B | 8.11B | 6.55B | |
Enterprise value | 13.27B | 15.97B | 14.83B | 15.73B | 13.21B | |
P/E ratio | 19.18 | 26.11 | 30.06 | 5.99 | 7.97 | |
Price to sales ratio | 1.32 | 1.68 | 1.46 | 1.71 | 1.34 | |
POCF ratio | 6.95 | -12.75 | 21.43 | 358.37 | 6.32 | |
PFCF ratio | 7.95 | -10.97 | 29.47 | -100.88 | 7.15 | |
P/B Ratio | 1.92 | 2.46 | 2.12 | 2.28 | 1.76 | |
PTB ratio | 1.92 | 2.46 | 2.12 | 2.28 | 1.76 | |
EV to sales | 3.02 | 3.47 | 3.22 | 3.31 | 2.69 | |
Enterprise value over EBITDA | 40.24 | 47.51 | 46.53 | 46.41 | 31.79 | |
EV to operating cash flow | 15.87 | -26.3 | 47.16 | 695.03 | 12.74 | |
EV to free cash flow | 18.13 | -22.63 | 64.86 | -195.66 | 14.43 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.04 | 0.03 | |
Free cash flow yield | 0.13 | -0.09 | 0.03 | -0.01 | 0.14 | |
Debt to equity | 2.57 | 2.71 | 2.64 | 2.26 | 2.32 | |
Debt to assets | 0.52 | 0.56 | 0.54 | 0.52 | 0.51 | |
Net debt to EBITDA | 22.61 | 24.47 | 25.39 | 22.48 | 16.04 | |
Current ratio | 1 | 1.28 | 1.21 | 1.3 | 1.04 | |
Interest coverage | 1.85 | 1.97 | 1.6 | 1.8 | 2.49 | |
Income quality | 11.09 | -8.24 | 5.63 | 0.07 | 5.05 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.37 | 0.39 | 0.51 | 0.08 | 0.14 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.51 | 0.5 | 0.5 | 0.5 | 0.45 | |
Capex to operating cash flow | -0.13 | 0.16 | -0.27 | -4.55 | -0.12 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -0.8 | -0.72 | -0.63 | -0.76 | -0.88 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
Graham number | 8.81 | 8.83 | 7.69 | 19.93 | 15.85 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.04 | 0.02 | |
Graham Net | -38.07 | -37.86 | -37.95 | -35.78 | -34.92 | |
Working capital | 6.1M | 750.92M | 628.47M | 849.92M | 190.06M | |
Tangible asset value | -4.59B | -4.49B | -4.48B | -4.12B | -3.9B | |
Net current asset value | -8.75B | -8.7B | -8.67B | -8.11B | -7.93B | |
Invested capital | 2.57 | 2.71 | 2.64 | 2.26 | 2.32 | |
Average receivables | 2.1B | 2.22B | 2.33B | 2.38B | 2.38B | |
Average payables | 1.12B | 1.21B | 1.12B | 1.09B | 1.23B | |
Average inventory | 533.64M | 561.1M | 589.7M | 601.38M | 585.8M | |
Days sales outstanding | 44.03 | 44.99 | 46.03 | 45.59 | 43.4 | |
Days payables outstanding | 30.09 | 23.63 | 24.5 | 21.87 | 28.89 | |
Days of inventory on hand | 12.56 | 12.32 | 13.13 | 12.37 | 11.88 | |
Receivables turnover | 2.04 | 2 | 1.96 | 1.97 | 2.07 | |
Payables turnover | 2.99 | 3.81 | 3.67 | 4.11 | 3.12 | |
Inventory turnover | 7.16 | 7.3 | 6.86 | 7.27 | 7.58 | |
ROE | 0.03 | 0.02 | 0.02 | 0.1 | 0.06 | |
Capex per share | -0.41 | -0.38 | -0.33 | -0.39 | -0.46 |
ARMK Frequently Asked Questions
What is Aramark stock symbol ?
Aramark is a US stock , located in Philadelphia of Pa and trading under the symbol ARMK
Is Aramark buy or a sell ?
9 stock analysts have 9 predictions with a medium analyst target price of $41.44. The lowest prediction is $36 and the highest is $45
What is ARMK stock prediction ?
What is Aramark stock quote today ?
Aramark stock price is $27.16 today.
Is Aramark stock public?
Yes, Aramark is a publicly traded company.